Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luh

Showing results (1441-1450 of 1,486) with videos related to

Pageof 149
Sort By:
The Journal of Investigative Dermatology|January 23, 2025
An S100A8/A9 Neutralizing Antibody Potently Ameliorates Contact Hypersensitivity and Atopic Dermatitis SymptomsYuma Gohara, Rie Kinoshita, Nahoko Tomonobu, et al.
American Journal of Hematology|July 18, 2013
Clinical implications of U2AF1 mutation in patients with myelodysplastic syndrome and its stability during disease progressionShang-Ju Wu, Jih-Luh Tang, Chien-Ting Lin, et al.
Blood Cancer Journal|January 4, 2023
Poor prognostic implications of myelodysplasia-related mutations in both older and younger patients with de novo AMLXavier Cheng-Hong Tsai, Kuo-Jui Sun, Min-Yen Lo, et al.
Blood|January 26, 2010
Distinct clinical and biologic characteristics in adult acute myeloid leukemia bearing the isocitrate dehydrogenase 1 mutationWen-Chien Chou, Hsin-An Hou, Chien-Yuan Chen, et al.
Antimicrobial Agents and Chemotherapy|February 5, 2020
Phase 2 Study of Anti-Human Cytomegalovirus Monoclonal Antibodies for Prophylaxis in Hematopoietic Cell TransplantationJohan Maertens, Aaron C Logan, Junho Jang, et al.
Cerebral Cortex (New York, N.Y. : 1991)|March 1, 2022
Age differences in the functional architecture of the human brainRoni Setton, Laetitia Mwilambwe-Tshilobo, Manesh Girn, et al.
Frontiers in Oncology|June 12, 2024
Dissection of the signal transduction machinery responsible for the lysyl oxidase-like 4-mediated increase in invasive motility in triple-negative breast cancer cells: mechanistic insight into the integrin-β1-NF-κB-MMP9 axisFan Jiang, Youyi Chen, Nahoko Tomonobu, et al.
Blood Cancer Journal|August 9, 2023
Validation of the molecular international prognostic scoring system in patients with myelodysplastic syndromes defined by international consensus classificationWan-Hsuan Lee, Ming-Tao Tsai, Cheng-Hong Tsai, et al.
Antimicrobial Agents and Chemotherapy|June 25, 2003
Telithromycin- and fluoroquinolone-resistant Streptococcus pneumoniae in Taiwan with high prevalence of resistance to macrolides and beta-lactams: SMART program 2001 dataPo-Ren Hsueh, Lee-Jene Teng, Tsu-Lan Wu, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|May 24, 2021
International Society of Oncology Pharmacy Practitioners (ISOPP) position statement: Role of the oncology pharmacy team in cancer careLisa M Holle, Tegan Bilse, Ramatu Masud Alabelewe, et al.
Pageof 149

Showing results (1441-1450 of 1,486) with videos related to

Sort By:
Pageof 149
The Journal of Investigative Dermatology|January 23, 2025
An S100A8/A9 Neutralizing Antibody Potently Ameliorates Contact Hypersensitivity and Atopic Dermatitis SymptomsYuma Gohara, Rie Kinoshita, Nahoko Tomonobu, et al.
American Journal of Hematology|July 18, 2013
Clinical implications of U2AF1 mutation in patients with myelodysplastic syndrome and its stability during disease progressionShang-Ju Wu, Jih-Luh Tang, Chien-Ting Lin, et al.
Blood Cancer Journal|January 4, 2023
Poor prognostic implications of myelodysplasia-related mutations in both older and younger patients with de novo AMLXavier Cheng-Hong Tsai, Kuo-Jui Sun, Min-Yen Lo, et al.
Blood|January 26, 2010
Distinct clinical and biologic characteristics in adult acute myeloid leukemia bearing the isocitrate dehydrogenase 1 mutationWen-Chien Chou, Hsin-An Hou, Chien-Yuan Chen, et al.
Antimicrobial Agents and Chemotherapy|February 5, 2020
Phase 2 Study of Anti-Human Cytomegalovirus Monoclonal Antibodies for Prophylaxis in Hematopoietic Cell TransplantationJohan Maertens, Aaron C Logan, Junho Jang, et al.
Cerebral Cortex (New York, N.Y. : 1991)|March 1, 2022
Age differences in the functional architecture of the human brainRoni Setton, Laetitia Mwilambwe-Tshilobo, Manesh Girn, et al.
Frontiers in Oncology|June 12, 2024
Dissection of the signal transduction machinery responsible for the lysyl oxidase-like 4-mediated increase in invasive motility in triple-negative breast cancer cells: mechanistic insight into the integrin-β1-NF-κB-MMP9 axisFan Jiang, Youyi Chen, Nahoko Tomonobu, et al.
Blood Cancer Journal|August 9, 2023
Validation of the molecular international prognostic scoring system in patients with myelodysplastic syndromes defined by international consensus classificationWan-Hsuan Lee, Ming-Tao Tsai, Cheng-Hong Tsai, et al.
Antimicrobial Agents and Chemotherapy|June 25, 2003
Telithromycin- and fluoroquinolone-resistant Streptococcus pneumoniae in Taiwan with high prevalence of resistance to macrolides and beta-lactams: SMART program 2001 dataPo-Ren Hsueh, Lee-Jene Teng, Tsu-Lan Wu, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|May 24, 2021
International Society of Oncology Pharmacy Practitioners (ISOPP) position statement: Role of the oncology pharmacy team in cancer careLisa M Holle, Tegan Bilse, Ramatu Masud Alabelewe, et al.
Pageof 149